Target intelligence / Profile preview

T-cell receptor-CD3 complex (TCR-CD3 complex) (TCR-CD3 complex)

Target
TCR-CD3 complex
Molecular classification
Receptor, Multi-subunit protein complex, Immunoglobulin superfamily
01

Overview

The T-cell receptor-CD3 complex (TCR-CD3 complex), historically referred to as the T3 complex, is a multi-subunit transmembrane assembly essential for the adaptive immune system (StatPearls, 2023). It consists of the antigen-binding T-cell receptor (TCR) heterodimer non-covalently associated with the invariant CD3 signaling modules, which include the gamma, delta, and two epsilon chains, along with a zeta-chain homodimer (UniProt, 2024). When the TCR recognizes a specific peptide-MHC complex, the CD3 subunits transduce the signal into the T cell via immunoreceptor tyrosine-based activation motifs (ITAMs), leading to T-cell proliferation and effector function (PubMed, 2021). This complex is a critical therapeutic target for managing organ transplant rejection and autoimmune disorders like Type 1 diabetes, where monoclonal antibodies like Teplizumab are used to modulate or deplete T-cell populations (NIH, 2022). Additionally, it is a cornerstone of modern cancer immunotherapy through bispecific T-cell engagers (BiTEs) that bridge CD3 on T cells to tumor-associated antigens to induce targeted cytotoxicity (Wikipedia, 2024). The structural integrity and signaling capacity of the TCR-CD3 complex are vital for immune surveillance, and its dysregulation is implicated in various autoimmune and lymphoproliferative disorders.

Other names
T3 complexCD3 complexT-cell receptor complexCD3 antigenT-cell surface glycoprotein CD3
02

Mechanism of action

Binding to the CD3 epsilon subunit to induce T-cell depletion, TCR internalization, or T-cell redirection to target cells

03

Biological functions

Signal transductionImmune responseT-cell activationAntigen recognition
04

Disease associations

Autoimmune diseaseGraft-versus-host diseaseType 1 diabetesCancerOrgan transplant rejection
05

Safety considerations

Cytokine release syndrome (CRS)Severe immunosuppressionInfusion-related reactionsNeurotoxicity
06

Interacting drugs

Muromonab-CD3

6 more in the full profile.

07

Biomarkers

CD3+ T-cell countTCR expressionCytokine levels (IL-2, IFN-gamma)Regulatory T-cell (Treg) levels

Beyond the preview

Go deeper on T-cell receptor-CD3 complex (TCR-CD3 complex) (TCR-CD3 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor-CD3 complex (TCR-CD3 complex) (TCR-CD3 complex).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call